These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 12847169)

  • 21. Secondary prevention of ischaemic stroke and TIA.
    Diener HC
    Cardiovasc J Afr; 2008; 19(4):229. PubMed ID: 18776974
    [No Abstract]   [Full Text] [Related]  

  • 22. [Aspirin versus anticoagulation in young patients with cerebral infarction secondary to primary antiphospholipid syndrome].
    Arauz A; Roa LF; Hernandez B; Merlos M; Marquez JM; Artigas C; Perez A; Cantu-Brito C; Barinagarrementeria F
    Rev Neurol; 2011 Nov; 53(10):584-90. PubMed ID: 22052173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antithrombotic therapy in ischemic stroke and transient ischemic attack].
    Overgaard K; Poulsen TS; Husted SE
    Ugeskr Laeger; 2007 Oct; 169(40):3379-82. PubMed ID: 17953858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anticoagulants, aspirin and dipyridamole in the secondary prevention of cerebral ischaemia: which is the best for which patient?
    Halkes PH; Algra A
    Cerebrovasc Dis; 2007; 24 Suppl 1():107-11. PubMed ID: 17971645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of cilostazol on cerebral arteries in secondary prevention of ischemic stroke.
    Guo JJ; Xu E; Lin QY; Zeng GL; Xie HF
    Neurosci Bull; 2009 Dec; 25(6):383-90. PubMed ID: 19927175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiphospholipid antibodies, infertility and recurrent miscarriage.
    Rai R; Regan L
    Curr Opin Obstet Gynecol; 1997 Aug; 9(4):279-82. PubMed ID: 9263721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin. The Stroke Prevention in Reversible Ischemia Trial (SPIRIT) Study Group.
    Ann Neurol; 1997 Dec; 42(6):857-65. PubMed ID: 9403477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term outcome in patients with cervical-artery dissections: There is still a lot to know.
    Leys D; Debette S
    Cerebrovasc Dis; 2006; 22(2-3):215. PubMed ID: 16778416
    [No Abstract]   [Full Text] [Related]  

  • 29. ADP-induced platelet aggregation in acute ischemic stroke patients on aspirin therapy.
    Cha JK; Jeon HW; Kang MJ
    Eur J Neurol; 2008 Dec; 15(12):1304-8. PubMed ID: 19049546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Triflusal and aspirin in the secondary prevention of atherothrombotic ischemic stroke: a very long-term follow-up.
    Alvarez-Sabín J; Quintana M; Santamarina E; Maisterra O
    Cerebrovasc Dis; 2014; 37(3):181-7. PubMed ID: 24503927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of combined aspirin and extended-release dipyridamole versus clopidogrel on functional outcome and recurrence in acute, mild ischemic stroke: PRoFESS subgroup analysis.
    Bath PM; Cotton D; Martin RH; Palesch Y; Yusuf S; Sacco R; Diener HC; Estol C; Roberts R;
    Stroke; 2010 Apr; 41(4):732-8. PubMed ID: 20181679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dissection of cervical arteries: Long-term follow-up study of 130 consecutive cases.
    Arauz A; Hoyos L; Espinoza C; Cantú C; Barinagarrementeria F; Román G
    Cerebrovasc Dis; 2006; 22(2-3):150-4. PubMed ID: 16691024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Warfarin or aspirin for recurrent ischemic stroke.
    Lewis SC; Sandercock PA
    N Engl J Med; 2002 Apr; 346(15):1169-71. PubMed ID: 11948280
    [No Abstract]   [Full Text] [Related]  

  • 34. Aspirin treatment failure and the risk of recurrent stroke and death among patients with ischemic stroke.
    Georgiadis AL; Cordina SM; Vazquez G; Tariq N; Suri MF; Lakshminarayan K; Adams HP; Qureshi AI
    J Stroke Cerebrovasc Dis; 2013 Feb; 22(2):100-6. PubMed ID: 21835634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anticoagulants versus antiplatelet agents for acute ischemic stroke.
    Hankey GJ; Berge E; Sandercock P
    Stroke; 2003 Jun; 34(6):1571-2. PubMed ID: 12764231
    [No Abstract]   [Full Text] [Related]  

  • 36. Choices in medical management for prevention of acute ischemic stroke.
    Fleck JD; Biller J
    Curr Neurol Neurosci Rep; 2001 Jan; 1(1):33-8. PubMed ID: 11898498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk-benefit profile of long-term dual- versus single-antiplatelet therapy among patients with ischemic stroke: a systematic review and meta-analysis.
    Lee M; Saver JL; Hong KS; Rao NM; Wu YL; Ovbiagele B
    Ann Intern Med; 2013 Oct; 159(7):463-70. PubMed ID: 24081287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Recurrent thromboses and hemorrhagic complications in patients with antiphospholipid syndrome during therapy with warfarin plus aspirin].
    Kondrat'eva LV; Patrusheva NL; Patrushev LI; Aleksandrova EN; Kovalenko TF; Ostriakova EV; Reshetniak TM
    Ter Arkh; 2010; 82(5):33-9. PubMed ID: 20597268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Ischemic stroke with antiphospholipid antibody].
    Kitagawa Y; Ohkuma H; Tokuoka K
    Brain Nerve; 2008 Oct; 60(10):1144-58. PubMed ID: 18975602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurologic manifestations of the antiphospholipid syndrome: integrating molecular and clinical lessons.
    Muscal E; Brey RL
    Curr Rheumatol Rep; 2008 Jan; 10(1):67-73. PubMed ID: 18457615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.